Early follicular GnRH [gonadotropin-releasing hormone] antagonist [ganirelix] supplementation improves fertilization and embryo cleavage rates in IVF-ET [in vitro fertilization pre-embryo transfer] GNRH antagonist cycles
Phase of Trial: Phase IV
Latest Information Update: 26 Jun 2008
At a glance
- Drugs Ganirelix (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 26 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2007 New trial record.